Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
51.1M
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
15M
-
Shares change
-
-416K
-
Total reported value, excl. options
-
$246M
-
Value change
-
-$10.2M
-
Number of buys
-
38
-
Number of sells
-
-20
-
Price
-
$16.60
Significant Holders of REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) as of Q4 2015
71 filings reported holding RGNX - REGENXBIO Inc. - Common Stock, par value $0.0001 per share as of Q4 2015.
REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15M shares
of 51.1M outstanding shares and own 29.32% of the company stock.
Largest 10 shareholders include FMR LLC (3.31M shares), BROOKSIDE CAPITAL MANAGEMENT LLC (1.93M shares), DEERFIELD MANAGEMENT CO (1.17M shares), VHCP Management II, LLC (1.03M shares), PRICE T ROWE ASSOCIATES INC /MD/ (973K shares), PERCEPTIVE ADVISORS LLC (779K shares), RS INVESTMENT MANAGEMENT CO LLC (747K shares), JPMORGAN CHASE & CO (359K shares), QVT Financial LP (352K shares), and Sectoral Asset Management Inc (351K shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.